Concepedia

Su Wang

SW

8

Publications

229

Citations

8

H-Index

1994

Active since

Affiliations

Sterling Research Group(Current)

South College

Sterling Research Group (United States)

Capital Medical University

Chinese Academy of Medical Sciences & Peking Union Medical College

Su Wang is an author at Sterling Research Group specializing in medicine, drug discovery, and natural sciences.

ORCID

Top concepts

Publications per year

1994–2021

8

Publications

8

Damnacanthal Is a Highly Potent, Selective Inhibitor of p56lck Tyrosine Kinase Activity

Connie R. Faltynek, Joseph A. Schroeder, Patricia Mauvais et al. · Biochemistry · 1995 · 76 citations

5,7-Dimethoxy-3-(4-Pyridinyl)Quinoline Is a Potent and Selective Inhibitor of Human Vascular .beta.-Type Platelet-Derived Growth Factor Receptor Tyrosine Kinase

Roland E. Dolle, Joseph A. Dunn, Mark A. Bobko et al. · Journal of Medicinal Chemistry · 1994 · 41 citations · Full text

, , +19

Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica

Tao Yang, Su Wang, Qi Zheng et al. · BMC Neurology · 2016 · 27 citations · Full text

Inhibition of T Lymphocyte Actnation by a Novel p56<sup>lck</sup>Tyrosine Kinase Inhibitor

Connie R. Faltynek, Su Wang, Deborah Miller et al. · Journal of enzyme inhibition · 1995 · 21 citations

RETRACTED ARTICLE: Effect of catalpol on remyelination through experimental autoimmune encephalomyelitis acting to promote Olig1 and Olig2 expressions in mice

Tao Yang, Qi Zheng, Su Wang et al. · BMC Complementary Medicine and Therapies · 2017 · 21 citations · Full text

Rows per page

1–5 of 8